Vitiligo, Alopecia Affect 1 in 20 Patients With GVHDVitiligo, Alopecia Affect 1 in 20 Patients With GVHD
In patients with chronic graft-vs-host disease (cGvHD), having a female stem cell donor or a female-donor-to-male-recipient sex mismatch is associated with an increased risk of vitiligo and alopecia areata, according to new findings. Reuters Health Information
Source: Medscape Dermatology Headlines - Category: Dermatology Tags: Dermatology News Source Type: news
More News: Alopecia | Alopecia Areata | Dermatology | Health | Skin | Stem Cell Therapy | Stem Cells | Vitiligo